157 related articles for article (PubMed ID: 34975134)
1. Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits.
Nagaraju B; Anilkumar KV
Indian J Pharmacol; 2021; 53(6):465-470. PubMed ID: 34975134
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo drug-drug interaction of losartan and glimepiride in rats and its possible mechanism.
Chen SZ; Pan PP; Wang SH; Luo J; Hu GX; Xu SS; Zhang L; Yu YF
Pharmacology; 2015; 95(3-4):133-8. PubMed ID: 25823852
[TBL] [Abstract][Full Text] [Related]
3. Effect of piperine on the pharmacokinetics and pharmacodynamics of glimepiride in normal and streptozotocin-induced diabetic rats.
Veeresham C; Sujatha S; Rani TS
Nat Prod Commun; 2012 Oct; 7(10):1283-6. PubMed ID: 23156991
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects.
Dawra VK; Cutler DL; Zhou S; Krishna R; Shi H; Liang Y; Alvey C; Hickman A; Saur D; Terra SG; Sahasrabudhe V
Clin Pharmacol Drug Dev; 2019 Apr; 8(3):314-325. PubMed ID: 29786959
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.
Kasichayanula S; Liu X; Shyu WC; Zhang W; Pfister M; Griffen SC; Li T; LaCreta FP; Boulton DW
Diabetes Obes Metab; 2011 Jan; 13(1):47-54. PubMed ID: 21114603
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic comparison of a new sustained-release formulation of glimepiride/metformin 1/500 mg combination tablet and a sustained-release formulation of glimepiride/metformin 2/500 mg combination tablet in healthy Korean male volunteers: a randomized, 2-sequence, 2-period, 2-treatment crossover study.
Shin KH; Kim SE; Yoon SH; Cho JY; Jang IJ; Shin SG; Yu KS
Clin Ther; 2011 Nov; 33(11):1809-18. PubMed ID: 22036245
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.
Stepensky D; Friedman M; Raz I; Hoffman A
Drug Metab Dispos; 2002 Aug; 30(8):861-8. PubMed ID: 12124302
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.
Kim KP; Lim KS; Kim BH; Shin HS; Cho JY; Shin SG; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):142-9. PubMed ID: 22257580
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat.
Zhou X; Zhang R; Zou Z; Shen X; Xie T; Xu C; Dong J; Liao L
Br J Pharmacol; 2019 Feb; 176(3):478-490. PubMed ID: 30471094
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.
Yun HY; Park HC; Kang W; Kwon KI
J Clin Pharm Ther; 2006 Oct; 31(5):469-76. PubMed ID: 16958825
[TBL] [Abstract][Full Text] [Related]
12. Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination.
Dong Y; Chen YT; Yang YX; Shou D; Li CY
Molecules; 2016 Oct; 21(11):. PubMed ID: 27809246
[TBL] [Abstract][Full Text] [Related]
13. Influence of losartan on the hypoglycemic activity of glimepiride in normal and diabetic rats.
Murthy TE; Kommineni MK; Mayuren C
Ther Adv Endocrinol Metab; 2013 Oct; 4(5):133-8. PubMed ID: 24143270
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic activity evaluation of glimepiride and Nerium oleander extract on insulin, glucose levels and some liver enzymes activities in experimental diabetic rat model.
Mwafy SN; Yassin MM
Pak J Biol Sci; 2011 Nov; 14(21):984-90. PubMed ID: 22514888
[TBL] [Abstract][Full Text] [Related]
15. Effects of Gymnema sylvestre extract on the pharmacokinetics and pharmacodynamics of glimepiride in streptozotocin induced diabetic rats.
Kamble B; Gupta A; Moothedath I; Khatal L; Janrao S; Jadhav A; Duraiswamy B
Chem Biol Interact; 2016 Feb; 245():30-8. PubMed ID: 26721197
[TBL] [Abstract][Full Text] [Related]
16. A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
Kasahara N; Fukase H; Ohba Y; Saito T; Miyata K; Iida S; Takano Y; Ikeda S; Harigai M; Terao K
Drug Res (Stuttg); 2016 Feb; 66(2):74-81. PubMed ID: 26158794
[TBL] [Abstract][Full Text] [Related]
17. Effects of glimepiride on in vivo insulin action in normal and diabetic rats.
Sato J; Ohsawa I; Oshida Y; Sato Y; Sakamoto N
Diabetes Res Clin Pract; 1993; 22(1):3-9. PubMed ID: 8137714
[TBL] [Abstract][Full Text] [Related]
18. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
19. Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus.
Machado HA; Vieira M; Cunha MR; Correia MR; Fukui RT; Santos RF; Rocha DM; Wajchenberg BL; Lage SG; Silva ME
Clinics (Sao Paulo); 2012 Jul; 67(7):711-7. PubMed ID: 22892913
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease.
Wang LP; Jiang Y; Yang H; Peng C; Zhang C; Tao X; Xie HH
Cell Physiol Biochem; 2016; 38(6):2337-47. PubMed ID: 27198152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
